News

September 11, 2024

Aardvark Therapeutics Expands Management Team with Two Key Hires : Chief Medical Officer, Head of Regulatory Affairs

San Diego, CA, September 10, 2024. Aardvark Therapeutics, Inc., a biopharmaceutical company, announced the appointment of Manasi Sinha Jaiman, M.D., M.P.H. as Chief Medical Officer and […]
May 14, 2024

New podcast: A new paradigm of appetite and hunger

In the  In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and […]
May 9, 2024

Aardvark Therapeutics Announces $85 Million Oversubscribed Series C Financing

Series C financing led by Decheng Capital and supported by a syndicate of new and existing investors including Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon […]
March 29, 2024

Weight loss biotech plans IPO as demand builds for anti-obesity treatments

Aardvark Therapeutics, a US biotech group developing a weight loss pill, is planning to raise up to $200m… Click here to read full article